General Information of Drug (ID: DMQMO4N)

Drug Name
SRF388 Drug Info
Indication
Disease Entry ICD 11 Status REF
Liver cancer 2C12 Phase 1 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMQMO4N

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-27 (IL27) TTC5LTG IL17D_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT04374877) Study of SRF388 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Surface oncology.